Bhupendra O. Khatri

To view the full text, please login as a subscribed user or purchase a subscription. Click here to view the full text on ScienceDirect. Fig. 1 Treatment Satisfaction Questionnaire for Medication Scores by Geographical Region for (A) Global Satisfaction, (B) Effectiveness, (C) Side Effects, and (D) Convenience ROW, rest of world; TSQM, Treatment Satisfaction Questionnaire for Medication. Fig.

Patients reported significant improvements in treatment satisfaction scores following the switch to teriflunomide regardless of the reason for treating with teriflunomide (Global Satisfaction, disease worsening: baseline, 46.0, Week 48, 65.1; convenience: baseline, 57.4, Week 48, 72.4; intolerance: baseline, 50.9, Week 48, 71.1; side effects: baseline, 49.7, Week 48, 67.2; P<0.0001 in all comparisons).

In 1999, Senator Orrin G. Hatch, a Utah Republican, played a pivotal role in pushing legislation in the 106th Congress that declared 2001-2010 as the “Decade of Pain Control and Research.” This bill encouraged physicians to treat pain aggressively, even when the treatment may increase the risk of death. In fact, the government made it a criminal offense to under-treat pain.